S-Alpha Therapeutics (에스알파테라퓨틱스)

Seoul, South Korea

Digital Therapeutics Therapeutics Clinical Trials Drug Development

Founded in 2019, S-Alpha Therapeutics develops digital therapeutics, a therapeutic intervention from the convergence of biology and information technology. Company has developed several digital therapeutic products in its R&D pipeline. Currently, company is conducting clinical trials to evaluate the efficacy, safety and feasibility of SAT-001 in several clinical sites in South Korea.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out S-Alpha Therapeutics (에스알파테라퓨틱스) on @MedStartr Today #DigitalTherapeutics #Therapeutics #ClinicalTrials #DrugDevelopment #MedMo #MedStartrVentures

https://www.medstartr.ai/s/aZrP7ynRzow

Get Involved in S-Alpha Therapeutics (에스알파테라퓨틱스)

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2019
Website: salphadtx.com/

Technologies

Digital TherapeuticsClinical TrialsBiotechnology

🌐Website

What do you think of S-Alpha Therapeutics (에스알파테라퓨틱스)?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.